The four-month-old is now waiting one hundred days to find out if the transplant was a success.

Our blood consists of many cell types that develop through different stages from a precursor type -- the blood stem cell. An international research team has now investigated the developmental pathways ...

Among the 13 CAR-T therapeutics that have received regulatory approval are Gilead’s Yescarta and Immuneel Therapeutics’ ...

Results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant ...

Did you know that donating blood can do more than just save a life? Here's what your blood can tell you about your health.

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

Olga Rivera Ballesteros from the Center for Infectious Medicine (CIM) at the Department of Medicine, Huddinge (MedH) is ...

Every second, an adult generates around five million new blood cells to replace aging or dying ones, making the blood system a highly regenerative organ.

The first patients have been dosed in a trial of CAR T therapy in relapsed/refractory T cell acute lymphoblastic leukemia or ...

New research shows how a specially trained population of immune cells keeps the peace by preventing other immune cells from attacking their own. The study provides a better understanding of immune ...

India's gene therapy for blood cancers shows 73% response rate, offering hope and cost-effective treatment for patients.

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...